2012 Acura MDX Advance
3.7 L • V6 • 300 hp • 4×4 • AT
2HNYD2H68CH545501
Sales history: 3
• $950Highlights
Condition
Run and drive
Seller
Insurance • Progressive Insurance
Key included
Yes
Docs
Good
History
3 records
Drive
3.7 L • V6 • 300 hp • 4×4 • AT
Odometer
207,194 mi ≈ 333,446 km
Primary damage
Front end
Docs
AL • Salvage
Extra
Auction
VIN
2HNYD2H68CH545501
Lot number
85527895
Copart
Sale status
Sold
Seller type
Insurance
Seller
Progressive Insurance
Location
Birmingham, AL
Description
Fuel type
Gasoline
Body color
Silver
Body type
SUV
Generation
YD2
Trim
Advance
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
2012 Acura MDX Advance • 3.7 L • V6 • 300 hp • 4×4 • Automatic • Copart Lot: 85527895 • VIN: 2HNYD2H68CH545501
Find out more about this 2012 Acura MDX Advance, available at the Copart salvage car auction as lot 85527895 in Birmingham, AL. This car has Front end main damage. It is listed with Run and drive start condition code. Odometer shows 207,194 mi. This Silver Acura MDX SUV is equipped with Gasoline 3.7 L engine, 4×4 drivetrain, Automatic transmission. Check the vehicle history report for 2HNYD2H68CH545501 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
